Get the Weekly Intelligence Brief — top committee picks every Sunday.
NTES · NASDAQ · STOCK

NetEase (NTES) Stock Analysis

Technology Updated October 10, 2026
$124.24
52W $106.06 – $153.54
62/100
$79.32B
16.2
0.77
AI Committee Verdict
Buy
62/100
Conviction: Contested · 67% agreement · 6 analysts
+9.8%
-0.6%
15.79:1
Contested

Is NTES Bullish or Bearish?

Bullish. Innellis AI committee rates NetEase, Inc. (NTES) Buy with a composite score of 62/100 , based on 6 analysts with 67% agreement. Last updated October 10, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +13.24 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -6.76 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+0.56 across 9 articles, 14d). Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • ROE of 20.1% shows genuine earnings power backing the valuation — Value
  • MACD histogram positive -- bullish momentum — Technical
  • Low leverage (debt-to-equity 0.04) -- balance sheet can absorb a shock — Risk
  • News sentiment is positive (+0.56 across 9 articles, 14d) — News
Bear Case
  • EPS declining -5.3% YoY despite any revenue growth — Growth
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
  • Price trading above the upper Bollinger Band -- stretched — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of October 10, 2026
Overall Committee Score
62/100
Agreement
67%
Analysts
6
Conviction
Contested
Sector Rank
Top 24%
of 287 Technology peers
Value Analyst bullish
65 / 100 · High confidence
Classic value case: cheap on multiples with earnings power to back it up
+ ROE of 20.1% shows genuine earnings power backing the valuation
Growth Analyst bearish
32 / 100 · High confidence
Growth story is weak, decelerating, or inconsistent
− EPS declining -5.3% YoY despite any revenue growth
Technical Analyst neutral
58 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− Price trading above the upper Bollinger Band -- stretched
Risk Analyst bullish
75 / 100 · Moderate confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
+ Low leverage (debt-to-equity 0.04) -- balance sheet can absorb a shock
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst bullish
76 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.56 across 9 articles, 14d)
Portfolio Manager bearish
30 / 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 61.8 to 61.8.

Analyst-level changes:
  • Technical Analyst: +1 bearish signal(s).

Comparing 2026-10-09 to 2026-10-10 (1 day apart).

Technical Analysis

RSI (14)
66.6
Neutral
MACD Histogram
0.683
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Lh Ll
Support
$123.47
Resistance
$136.40
Bollinger %B
1.10
Above Upper Band
Price vs Moving Averages
EMA 9
$120.42 Above
EMA 21
$119.87 Above
EMA 50
$121.09 Above
EMA 200
$123.33 Above

Fundamental Analysis

Valuation
90
Growth
27
Profitability
100
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio 16.2×
P/B Ratio 3.16×
PEG Ratio -2.86
Dividend Yield 2.38%
52W High $153.54
52W Low $106.06
Quality & Growth
ROE 2104.8%
ROA 1523.8%
Gross Margin 6715.1%
Operating Margin 3522.4%
Revenue Growth YoY —
Debt / Equity 0.08
AI Fundamental Assessment
P/E ratio of 16.2 (inexpensive relative to a 15-40x range); Price-to-book of 3.2x; PEG ratio of -2.9 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 21.0%; Return on assets of 15.2%; Net margin of 27.9%; Gross margin of 67.2%; Current ratio of 3.45 (healthy short-term liquidity); Debt-to-equity of 0.08; Free cash flow per share is positive (78.64); Most recent quarter missed estimates by 22.5%; EPS growth decelerating (+59.5% -> -31.2% QoQ); Average YoY EPS growth of -18.8%; Analyst estimates rising over recent quarters
Get the Full NTES Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime